NCT05538832

Brief Summary

The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jul 2022

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 5, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 3, 2025

Status Verified

October 1, 2025

Enrollment Period

3.2 years

First QC Date

August 5, 2022

Last Update Submit

October 1, 2025

Conditions

Keywords

Cognitive TrainingRemoteOnlineClinical Trial

Outcome Measures

Primary Outcomes (2)

  • Change in Performance of Dot Pattern Expectancy (DPX) Task Variant

    The DPX task variant consists of a series of pattern sequences. One pattern is designated the "A" cue, and another the "X" cue, which requires one response (AX, 60-70% of trials, e.g. respond with the left button), while other sequences require a different response (AY or BX, 12-15% of trials each, or BY, 6-10% of trials, e.g. respond with the right button). Given the strong expectation that X's evokes a valid response, BX trials place demands on the fidelity (stability, memory) of the "B" cue state representation to overcome this tendency.

    Baseline, Immediately after the intervention, 5 month follow up

  • Change in Performance of Bandit Task Variant

    This is a task variant that uses choice options (neutral images) that are rewarded probabilistically. The rewarded stimulus with the highest reward is changed over time. State learning associated with staying or switching stimuli too quickly (lose-switching) can be evaluated.

    Baseline, Immediately after the intervention, 5 month follow up

Secondary Outcomes (8)

  • Change in Test My Brain Neurocognitive Assessment performance: Global Cognition Z Score.

    Baseline, Immediately after the intervention, 5 month follow up

  • Change in Test My Brain Neurocognitive Assessment performance: Verbal Pair Associates Memory Z Score

    Baseline, Immediately after the intervention, 5 month follow up

  • Change in Test My Brain Neurocognitive Assessment performance: Matrix Reasoning Z Score

    Baseline, Immediately after the intervention, 5 month follow up

  • Change in Test My Brain Neurocognitive Assessment performance: Multiracial Emotion Identification Z Score

    Baseline, Immediately after the intervention, 5 month follow up

  • Change in symptoms and functioning as indicated by Minnesota Symptom Severity Scale

    Baseline, Immediately after the intervention, 5 month follow up

  • +3 more secondary outcomes

Study Arms (2)

Visual Perception Training

EXPERIMENTAL

Contains targeted visual perception exercises from BrainHQ's suite of cognitive exercises. This training paradigm is designed to improve state estimation processes at the perceptual input level.

Device: BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm

Visual Cognitive Control Training

EXPERIMENTAL

Contains targeted visual cognitive control exercises from BrainHQ's suite of exercises. This training paradigm is designed to enhance state representation stability of visual information.

Device: BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm

Interventions

The Cognitive Training is a program consisting of the follow set of exercises developed by Posit Science Corporation (BrainHQ) which is to be evaluated for Visual Perception Training: Visual Sweeps; Mind's Eye; Hawk Eye; and Divided Attention. Participants use a standard web browser on a broadband connected computer and go to the study web site. Participants perform multiple trials over the course of a session, with auditory/visual feedback and rewards to indicate if the trial was performed correctly or incorrectly. After each assigned session, the difficulty of the next session is updated to ensure that each participant is appropriately challenged.

Visual Perception Training

The Cognitive Training is a program consisting of the follow set of exercises developed by Posit Science Corporation (BrainHQ) which is to be evaluated for Visual Cognitive Control Training: Mind Bender; Divided Attention; Card Shark; and Freeze Frame. Participants use a standard web browser on a broadband connected computer and go to the study web site. Participants perform multiple trials over the course of a session, with auditory/visual feedback and rewards to indicate if the trial was performed correctly or incorrectly. After each assigned session, the difficulty of the next session is updated to ensure that each participant is appropriately challenged.

Visual Cognitive Control Training

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All Participants:
  • Between the ages of 18-30 at the time of screening
  • Fluent in spoken and written English, in that the participant learned to speak English before the age of 12 or is able to demonstrate fluency in conversation with study staff
  • Has an outpatient status and no hospitalization for psychiatric reasons for at least 1 month prior to participant
  • Has access to a computer with internet connection
  • Has a United States address as permanent residence
  • Estimated IQ at or above 70, as estimated by the cognitive assessments
  • Early Psychosis Participants:
  • Diagnosis of one of the following conditions (confirmed via interview): schizophrenia; schizoaffective disorder; schizophreniform disorder; Psychosis not otherwise specified (NOS); major depressive disorder with psychotic features; bipolar disorder with psychotic features
  • Willing to share contact with a clinical provider

You may not qualify if:

  • All participants:
  • History of severe substance use in the past 3 months (determined by interview)
  • Unable to demonstrate capacity to consent to research, in the judgment of the study team
  • Diagnosed with a neurological disorder that would impede participation in the study or would put the participant at additional risk by participating, in the opinion of the PI/CO-Is
  • Previous clinically significant head injury or prolonged unconsciousness
  • Significant cognitive training experience in the past 6 months
  • Meets criteria for clinical risk of suicidal behavior.
  • Non-Psychosis participants:
  • Meets DSM-5 criteria for a psychotic, bipolar, or autism spectrum disorder
  • Has a family history (1st degree relative) of psychosis, bipolar, or autism spectrum disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55454, United States

Location

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaAffective Disorders, PsychoticSchizophrenia Spectrum and Other Psychotic Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Caroline Demro, PhD

    University of Minnesota Department of Psychiatry and Behavioral Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The investigator will not know the treatment condition until the trial is completed. Participants will not be notified of which group they are assigned. The study coordinator will be aware of assignment but will not complete any outcomes assessments--these will be self-report.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2022

First Posted

September 14, 2022

Study Start

July 27, 2022

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

October 3, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations